Global Interleukin-11 (IL-11) Market Research Report 2022

Interleukin-11 (IL-11) is a protein that comes from bone marrow stromal cells.It can enhance interleukin-3 to stimulate the growth of megakaryocytes.The activity was similar to interleukin-6 and interleukin-7, but the chemical structure was significantly different, without cysteine residues.
Due to the COVID-19 pandemic, the global Interleukin-11 (IL-11) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Interleukin-11 (IL-11) market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Interleukin-11 (IL-11) landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Above 90% accounting for % of the Interleukin-11 (IL-11) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Natural Biological Products segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Interleukin-11 (IL-11) include Johnson & Johnson, Roche, Pfizer, Shanghai Sailun Bio-tech, Xiamen Tebao Bio-engineering, Angde Bio-pharmaceutical, Hangzhou Jiuyuan Genetic Engineering, Qilu Pharmaceutical and Shanghai Huaxin Bio-tech, etc. In terms of revenue, the global 3 largest players have a % market share of Interleukin-11 (IL-11) in 2021.
This report focuses on Interleukin-11 (IL-11) volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Interleukin-11 (IL-11) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Interleukin-11 (IL-11) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Above 90%
Above 95%
Above 99%
Others
Segment by Application
Natural Biological Products
Monoclonal Antibody
Recombinant Interleukin
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Johnson & Johnson
Roche
Pfizer
Shanghai Sailun Bio-tech
Xiamen Tebao Bio-engineering
Angde Bio-pharmaceutical
Hangzhou Jiuyuan Genetic Engineering
Qilu Pharmaceutical
Shanghai Huaxin Bio-tech
Beijing Shuanglu Pharmaceutical
Beijing Four Rings Bio-Pharmaceutical
Beijing Yuance Pharmaceutical
Shandong Quangang Pharmaceutical